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a b s t r a c t
Respiratory syncytial virus RNA dependent RNA polymerase (RdRp) initiates RNA synthesis from the
leader (le) and trailer-complement (trc) promoters. The RdRp can also add nucleotides to the 30 end of the
trc promoter by back-priming, but there is no evidence this occurs at the le promoter in infected cells.
We examined how environmental factors and RNA sequence affect de novo RNA synthesis versus back-
priming using an in vitro assay. We found that replacing Mg2þ with Mn2þ in the reaction buffer
increased de novo initiation relative to back-priming, and different lengths of trc sequence were required
for the two activities. Experiments with le RNA showed that back-priming occurred with this sequence
in vitro, but less efﬁciently than with trc RNA. These ﬁndings indicate that during infection, the RdRp is
governed between de novo RNA synthesis and back-priming by RNA sequence and environment,
including a factor missing from the in vitro assay.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Respiratory syncytial virus (RSV), a signiﬁcant cause of severe
acute lower respiratory disease (Nair et al., 2010), belongs to the
family Paramyxoviridae in the order Mononegavirales. Members
of this order of viruses have a single stranded, negative sense
RNA genome, which is transcribed and replicated by the viral RNA
dependent RNA polymerase (RdRp). In comparison to the RdRps of
positive and double stranded RNA viruses, which have been
extensively studied, very little is known about the RdRps of negative
strand RNA viruses, and in particular the non-segmented negative
strand (NNS) RNA viruses.
Like other NNS RNA viruses, the RSV RdRp initiates RNA
synthesis from two promoters: the leader (le) promoter that lies
at the 30 end of the genome RNA, which signals initiation of mRNA
transcription and RNA replication, and the trailer complement (trc)
promoter that lies at the 30 end of the replicative intermediate
RNA, the antigenome, which signals synthesis of RNA replication
to produce genome RNA (Cowton et al., 2006). Recent studies have
shown that the RSV RdRp has complex activities at the promoters,
and in particular, at the trc promoter. It can initiate RNA synthesis
at positions þ1 and þ3 of both the le and trc promoters (Fig. 1A)
(Noton et al., 2010, 2012; Noton and Fearns, 2011; Tremaglio et al.,
2013). In addition, it can extend the 30 terminus of trc RNA using a
back-priming mechanism in which the RNA folds into a secondary
structure and the RdRp adds predominantly G, GU, or GUC using
the internal RNA sequence as a template (Noton et al., 2012)
(Fig. 1B). In infected cells, this leads to a heterogeneous population
of trc-containing RNA, with approximately 40% of transcripts
modiﬁed by 30 extension. In contrast, there was no evidence for
30 modiﬁcation of le containing RNA isolated from infected cells
(Noton et al., 2012). The signiﬁcance of 30 extension at the trc
promoter is unknown, but in the context of naked RNA, the
additional nucleotides inhibit promoter activity, suggesting that
30 extension may represent a mechanism by which the activity of
the trc promoter is regulated.
The ﬁnding that the RdRp could perform back-priming on trc
RNA was surprising because NNS RNA virus replicative RNA is
encapsidated with nucleoprotein (N) throughout infection. Atomic
structures of N–RNA complexes from several NNS RNA viruses,
including RSV, suggest that encapsidated RNA would be devoid of
secondary structure (Albertini et al., 2006; Bakker et al., 2013;
Green et al., 2006; Tawar et al., 2009). However, the ﬁnding that
back-priming at the trc promoter can occur in RSV infected cells
indicates that this promoter containing RNA can adopt a secondary
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structure and so presumably is unencapsidated, at least some of
the time, during infection. This ﬁnding is in keeping with other
information obtained regarding RSV, including the fact that
although each N monomer binds seven nt, the RSV genome
nucleotide length is not divisible by seven, and in contrast to
many other paramyxoviruses, RSV template activity is not sensi-
tive to insertions and deletions that would disrupt any phasing
that exists between N protein and the RNA (Kolakofsky et al.,
2005; Samal and Collins, 1996). In addition, RNA probes have been
shown to hybridize speciﬁcally to RSV genome RNA in infected
cells (Jung et al., 2013; Liﬂand et al., 2012; Lindquist et al., 2010;
Santangelo et al., 2009), indicating that there are occasions when
some of the RNA is at least transiently exposed. Together, these
observations lend support to the idea that the RSV promoters
might not always be completely encapsidated during infection.
The ability of the RdRp to interact with trc to perform either de
novo RNA synthesis or 30 extension by back-priming indicates that
it can engage the promoter in two completely different conﬁgura-
tions (Fig. 1, compare A and B). Given that 30 extension and de novo
RNA synthesis involve the RdRp interacting with trc RNA in two
different ways, it would be valuable to have a greater under-
standing of factors that inﬂuence RdRp activity when it encounters
the trc sequence, and to determine if sequence differences
between le and trc account for why le RNA is not modiﬁed by 30
extension in RSV infected cells. Thus, the aim of the work
described here was to examine how environment and RNA
sequence affect RdRp activities at the promoter.
Results
Characterization of the products generated in an in vitro
RNA synthesis assay
The de novo RNA synthesis and 30 extension activities of the
RSV RdRp were reconstituted in an in vitro RNA synthesis assay,
described previously (Noton et al., 2012). Recombinant RSV RdRp,
consisting of puriﬁed complexes of the large polymerase subunit
(L) and phosphoprotein (P), was incubated with an RNA oligonu-
cleotide consisting of nucleotides 1–25 of trc promoter sequence
and all four NTPs, including [α32P] GTP. As a negative control, RNA
synthesis reactions were performed with a mutant RdRp, in which
the L component of the RdRp contained an N812A mutation in the
RNA synthesis catalytic site (Fig. 2A, lane 4), or the RdRp was
omitted from the reaction (Fig. 2A, lane 3). Similarly to previously
published results, wt RSV RdRp generated a number of transcripts
(Fig. 2A, lane 5). Bands Z26 nt represent products of 30 extension
(Noton et al., 2012). These bands typically appeared as a triplet of
products 26, 27 and 28 nt in length, corresponding to addition of
one, two or three nucleotides (see also Fig. 2D). Longer exposures
also revealed smaller amounts of longer products of appropriate
length of RNA generated by RdRp that engaged in back-priming,
but extended to the end of the template (Fig. 2D, lane 10).
The products of de novo RNA synthesis products appeared as a
ladder of bands 6–25 nt in length with a dominant band at 21 nt.
There were also dominant bands at 8 and 9 nt which likely
represent abortive initiation products generated by RdRp that
failed to escape the promoter (Fig. 2A, lane 5). As described in
the Introduction, in infected cells the RSV RdRp initiates at the þ1
and þ3 sites on the trc promoter. To examine if this was the case
in the in vitro assay, RNA synthesis reactions were performed
either with [γ-32P] ATP or [γ-32P] GTP, rather than [α-32P] GTP, to
detect RNA initiated at þ1U or þ3C, respectively. Reactions
containing [γ-32P] ATP yielded products up to 25 nt in length,
with dominant bands at 21–25 nt (Fig. 2B, lane 6). In contrast,
reactions containing [γ-32P] GTP yielded products up to 23 nt in
length, with a dominant band at 21 nt (Fig. 2C, lane 6). These
results conﬁrmed that RNAs were initiated at þ1 and þ3,
respectively, but RNA initiated from þ1 could only be detected
following long reaction times, and the signal was consistently
weak, indicating that initiation from this site was relatively
inefﬁcient. Thus, bands characterized as de novo synthesized RNA
include RNA transcripts initiated from þ1 and þ3, but with RNA
initiated at þ3 being dominant.
In the experiment shown in Fig. 2A, the 30 extension bands are
very strong compared to bands representing de novo RNA synth-
esis products. This was somewhat surprising given that it is
believed the major function of the trc sequence is to direct
initiation of de novo RNA synthesis, and RNA from infected cells
showed that not all the trc RNA was modiﬁed by back-priming
(Noton et al., 2012). To conﬁrm that the high level of 30 extension
was not an artifact of extended incubation times, RNA synthesis
reactions were incubated for varying lengths of time. This analysis
showed that the products of de novo RNA synthesis and 30
extension could both be detected following a 5 min incubation
period, and that their ratios did not change over the timecourse
(Fig. 2D, lanes 4–10; Fig. 2E). This was also the case if the reaction
conditions were varied (data not shown). These data showed that
Fig. 1. Different conﬁgurations of the RdRp and RNA at the trc promoter. (A, B) The 30 25 nt of the trc promoter region, which correlate with the RNA template used
previously in reconstituted RNA synthesis assays (Noton et al., 2012), are shown. Nucleotides 13 and 14, which are involved in back-priming, are indicated with black dots.
The RdRp is shown as a shaded oval, with the priming and incoming nucleotide sites shown as white boxes. (A) Orientation and positioning of the RdRp relative to the trc
RNA for de novo RNA synthesis from position þ3 of the trc promoter. The arrow points to the full-length product that would be generated from this site in the in vitro assay.
The RdRp can also initiate at position þ1 to generate the product shown in parentheses, but the initiation mechanism has not been characterized. (B) Orientation of the RdRp
and trc RNA for back-priming and 30 extension, with nucleotides 13C and 14A base-paired with nucleotides 2G and 1U, respectively. The arrow points to the 28 nt product
that is generated when the 30 end of the RNA is extended by three nucleotides. In addition, in the in vitro assay, nucleotides 1 and 2 can base-pair with nucleotides 15 and 16,
to prime addition of CTP to the 30 end of the template RNA (not shown).
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the relative levels of 30 extension and de novo RNA synthesis did
not vary over time in the in vitro RNA synthesis assay.
30 extension and de novo RNA synthesis are differentially affected by
divalent cations
Metal cations are required for polymerization activity. They
function to coordinate incoming NTPs and allow phosphoryl
transfer (Yang et al., 2006). In most cases Mg2þ , which is abundant
in cells and has stringent coordination requirements, is optimal.
However, Mn2þ , which has a similar chemistry to Mg2þ , but
relaxed coordination requirements, often can be used (Yang et al.,
2006). Substituting Mg2þ with Mn2þ can alter RdRp structure and
has been shown to have complex effects on the activities of viral
RdRps (Arnold et al., 1999, 2004; Butcher et al., 2001; Palmenberg
and Kaesberg, 1974; Ranjith-Kumar et al., 2002a, 2002b; Shim
et al., 2002). In the case of the RSV RdRp, the ﬁrst step in initiation
at the promoter must involve polymerization of two NTPs (de novo
initiation), whereas back-priming and 30 extension involves
nucleotide addition to the 30 end of an existing RNA (Fig. 1).
Studies with positive strand RNA viruses have shown that
Fig. 2. Characterization of the products generated in an in vitro RNA synthesis assay. (A) Products of the RSV RdRp in an in vitro assay. The RSV RdRp was incubated for 3 h
with a template representing nucleotides 1–25 of the trc promoter sequence in a buffer the same as standard reaction buffer, except that it contained 1 mM ATP, CTP and UTP
and 250 mM GTP with [α-32P] GTP. The products were migrated directly on a denaturing polyacrylamide gel. Lane 3 is a negative control in which the L/P complex was
omitted from the reaction, and lane 4 is a negative control in which reactions were incubated with the L/P complex containing the N812A substitution at the catalytic site of
the L protein. (B, C) De novo RNA synthesis involves initiation from the þ1 and þ3 sites. RSV RdRp was incubated for 6 h with a template representing nucleotides 1–25 of
the trc promoter sequence in a buffer that was the same as the standard reaction buffer, except that the NTP concentrations were reduced to 500 mM each, supplemented
with either [α-32P] UTP (B, C, lane 3), [γ-32P]ATP (B, lanes 4–6) or [γ-32P]GTP (C, lanes 4–6). (D) Accumulation of RNA synthesis products over time. The RSV RdRp was
incubated with a template representing nucleotides 1–25 of the trc promoter sequence in a standard reaction buffer, including [α-32P] GTP, and incubated for the times
indicated before heat inactivation of the RdRp. In panels A–D, lanes 1 and 2 contain size markers representing nt 3–25 or 1–25 of tr, the expected products of þ3 and þ1 de
novo RNA synthesis, respectively. (E) Graph showing quantiﬁcation of the RNA products shown in panel D. The 21 nt and 26–28 nt bands representing de novo RNA synthesis
products and products of 30 extension, respectively, were quantiﬁed. In each case, the values were normalized to the 1 h time point value, which was set to 1. This graph
represents one of three independent experiments, each performed with slightly varied reaction conditions and time points.
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substituting Mg2þ with Mn2þ can alter the relative efﬁciencies of
de novo versus primed initiation (Arnold et al., 1999; Ranjith-
Kumar et al., 2002b). Therefore, we examined if de novo RNA
synthesis and 30 extension were differentially affected by Mg2þ
versus Mn2þ . In addition, the relative levels of short and long de
novo RNA synthesis products were examined to determine if Mg2þ
and Mn2þ had different effects on initiation versus elongation of
de novo synthesized RNA.
RNA synthesis assays were performed either lacking metal
cations, or with either Mg2þ or Mn2þ included at a range of
concentrations from 1 mM to 16 mM. Following the reaction, RNA
products were treated with calf intestinal phosphatase (CIP) to
improve the signal to background ratio near the bottom of the gel.
It should be noted that the phosphatase treatment caused RNA
transcripts r6–10 nt to migrate differently from the markers
(because they lack 50 phosphate) and instead these bands migrated
between the 8 and 10 nt markers. In the absence of metal cations,
no RNA synthesis products were detected (Fig. 3A and B, lane 4).
Increasing the concentration of Mg2þ promoted all RNA synthesis
activities, with the highest levels of de novo RNA synthesis and 30
extension being observed at 8 mM MgCl2 (Fig. 3A). There was a
change in the pattern of nucleotide addition during 30 extension,
with higher Mg2þ concentrations increasing the frequency of
two and three nucleotide additions (compare lane 7 with lanes
8 and 9). However, aside from this difference, the relative levels of
de novo initiation, elongation, and 30 extension were not differentially
affected by varying Mg2þ . Addition of Mn2þ to the reactions instead
of Mg2þ also enabled de novo initiation and 30-extension (Fig. 3B, lanes
5–7), demonstrating that RSV RdRp could use this as an alternative
metal cation for both processes, but at higher concentrations (8 and
16mM)Mn2þ was inhibitory (Fig. 3B, lanes 8 and 9). Whereas varying
Mg2þ concentration had only subtle or negligible effects on the
different RdRp RNA synthesis activities, this was not the case for
Mn2þ . Inclusion of Mn2þ at the lowest concentration tested (1 mM)
supported relatively efﬁcient initiation of de novo RNA synthesis,
resulting in accumulation of products migrating at 8–10 nt, and the
levels of these products were only increased approximately 2–3 fold as
the concentration of Mn2þ was increased to 4 mM. However, compar-
ison of the intensity of bands migrating at 8–10 nt with the 21 nt band
indicated that while Mn2þ supported initiation of RNA synthesis at a
relatively high level, it was inefﬁcient at supporting RNA synthesis
elongation (Fig. 3, compare panels A and B). In contrast, at the lowest
concentrations tested (1 and 2mM) Mn2þ supported only a relatively
low level of 30 extension, but the efﬁciency of 30 extension increased
substantially as the concentration of Mn2þ was increased from 2 to
4 mM, similarly to the results obtained with Mg2þ . Thus, the RdRp
performed the activities of 30 extension and de novo RNA synthesis
differently depending on the identity and concentration of metal
cation available, with lower concentrations of Mn2þ favoring de novo
initiation versus 30 extension.
NaCl, DMSO and glycerol, which have previously shown to
affect activities of other RdRps (Chen and Patton, 2000; Paul et al.,
1998), were examined to determine if they had an effect on the
RSV RdRp. None of these factors affected the relative levels of
30 extension and de novo RNA synthesis. NaCl was found to be
inhibitory to all RNA synthesis, particularly at concentrations
Z100 mM, glycerol was found to slightly enhance RNA synthesis,
and DMSO had no detectable effect (data not shown).
The ﬁrst 12 nt of the trc promoter are sufﬁcient for de novo RNA
synthesis
Having found that 30 extension and de novo RNA synthesis
occur under each of the experimental conditions that were tested,
Fig. 3. Effect of Mg2þ and Mn2þ on the activities of the RSV RdRp. (A, B) 200 ng of L/P RdRp preparation was combined with a buffer similar to standard buffer, containing
[α-32P] GTP, but lacking glycerol, and with between 0 and 16 mM MgCl2 or MnCl2, as indicated. The template represented nucleotides 1–25 of the trc promoter sequence and
reaction mixes was incubated for 2 h. RNA was analyzed by denaturing urea–acrylamide gel electrophoresis and autoradiography. Lanes 1 and 2 contain molecular weight
ladders representing the expected products of de novo RNA synthesis from positions þ3 and þ1, respectively. Lane 3 is a negative control in which reactions were incubated
with the L/P complex containing the N812A substitution at the catalytic site. (C, D) Bar charts showing levels of abortive initiation, elongation and 30 extension products with
different concentrations of Mg2þ (panel C) and Mn2þ (panel D). The 8–10 nt, 21 nt and 26–28 nt bands were quantiﬁed. The data show the mean and range of two
independent experiments. The data from each experiment were normalized to 30 extension at 2 mM, which was set to a value of 1. Note that no correction was made for the
expected number of [α-32P] GTP incorporation sites in each of the products, and that while the trends between the Mg2þ and Mn2þ bar charts can be directly compared, the
absolute values cannot be.
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we examined the contribution of different regions of the trc
promoter to the two different RNA synthesis activities. Previous
studies had indicated that there was a core promoter element
located within nucleotides 1–12 of the le and trc promoter regions
(Cowton and Fearns, 2005; Fearns et al., 2002; Peeples and Collins,
2000). However, it was not known if nucleotides 1–12 contain all
the signals required to direct initiation of RNA synthesis, or if
sequence beyond the ﬁrst 12 nt impacts RdRp behavior during de
novo RNA synthesis. To investigate this, templates consisting of the
30 terminal 12, 14, 16, 20 and 25 nt of trc sequence were analyzed
(Fig. 4A). RNA synthesis reactions were performed that included
templates together with all four NTPs and [γ-32P] GTP to allow
analysis of RNA initiated from position þ3, the dominant de novo
synthesized product (Fig. 4B). The 12 nt template yielded abun-
dant RNA synthesis products, with a dominant band at 10 nt,
which would correlate with RNA initiated at position 3 and
extended to the end of the template. Increasing the length of the
template to 14 and 16 nt had no signiﬁcant effect on the levels of
Fig. 4. Impact of trc template length on RSV RdRp activities. (A) Templates representing the 30 12, 14, 16, 20 or 25 nt of the trc promoter. (B) RNA templates illustrated in panel A
were combined with standard buffer, but containing 250–500 mM each NTP (depending on the experiment) and [γ-32P] GTP, and incubated for 2–5 h (depending on the
experiment). (C) RNA templates were incubated for 30 min in standard RNA synthesis buffer, including [α-32P] ATP. (D) RNA templates were incubated for 30 min in standard
RNA synthesis buffer containing [α-32P] GTP and either all four NTPs (4) or GTP alone (G) and wt RdRp. In panels B and C, lanes 1 and 2 are negative controls in which either no
RdRp or RdRp containing the N812A substitution in the L protein was included in the reaction, respectively. The sizes of the RNA products were determined by comparisonwith
the markers shown in Figs. 2 and 3. (E) Bar chart showing the levels of de novo RNA synthesis from each of the templates as measured by quantiﬁcation of [γ32P] GTP containing
RNA products as shown in panel B, and [α-32P] ATP products as shown in panel C. For quantiﬁcation, all detectable bands, not including the stuttering products, from the 12, 14,
and 16 nt templates were measured. Each bar represents the mean and standard error of three or four independent experiments. The data from each experiment were
normalized to the product from the 12 nt template, which was set to a value of 1. Note that it was not possible to accurately quantify the levels of de novo RNA synthesis for the
20 and 25 nt templates because the signal is distributed between many faint bands. (F) Bar chart showing the levels of 30 extension from each of the templates as measured by
quantiﬁcation of [α-32P] GTP containing RNA in reactions containing GTP as the only NTP, as shown in panel D, lanes 2, 4, 6, 8 and 10. Each bar represents the mean and standard
error of three independent experiments. The data from each experiment were normalized to the product from the 25 nt template, which was set to a value of 1.
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products, indicating that nucleotides 13–16 are not required for
promoter activity (Fig. 4B, lanes 3–5; Fig. 4E). Further increases in
template length appeared to slightly suppress de novo RNA
synthesis (Fig. 4B, lanes 6 and 7). Similar results were obtained
in reactions containing [α32P] ATP, which would allow detection of
RNA initiated from þ1 and þ3 (Fig. 4C), and [α32P] GTP, which
would allow detection of de novo RNA synthesis from þ1 and þ3
and 30 extension activity (Fig. 4D, lanes 1, 3, 5, 7, and 9). These data
show that the promoter for de novo RNA synthesis is contained
within the 30 12 nt of trc.
It was noticeable that the 12, 14 and 16 nt templates each
yielded a ladder of bands that were longer than the input
templates (Fig. 4B and C, lanes 3–5; Fig. 4D, lanes 1, 3, and 5).
The relative intensities of these bands were increased if [α32P]-ATP
was used as a label instead of [α32P]-GTP, indicating that these
longer products arose as a consequence of additional A residues
being inserted into the products (Fig. 4, compare panels C and D).
As RSV RdRp stuttering at a U6 tract has been reported previously
(Garcia-Barreno et al., 1990), it seemed likely that these products
are the result of RdRp stuttering on a U7 stretch that extends from
nucleotides 6–12 of the trc promoter. The levels of stutter products
decreased as the length of the template was increased to 16 nt, but
remained at a detectable level. We hypothesized that the RSV
RdRp might be particularly prone to stuttering within the promo-
ter, before it had undergone conformational changes that enabled
it to enter a stable elongation mode. To examine if this is the case,
we analyzed data from next generation sequencing experiments
performed on poly A enriched RNA isolated from RSV infected cells
and determined the frequency of one or more nucleotide inser-
tions at this trc U7 tract. This analysis showed that 1.25% of trc
and tr containing RNA transcripts contained additional A and U
residues. A similar or slightly higher stuttering frequency was
found at the other U7 tracts within the RSV genome (r3.84%)
(Table 1). A higher stuttering frequency was also found in cellular
mRNAs with similarity to the RSV G gene (5%). These ﬁndings
suggest that the RSV RdRp is not especially prone to stuttering at
the trc U7 tract during RNA replication in infected cells, or that if it
does stutter at this site, it does not continue to elongate the RNA.
More than 16 nt of trc sequence are required for efﬁcient 30 extension
As described above, 30-extension involves base-pairing of
nucleotides 1 and 2 with nucleotides 13 and 14 to form a hairpin
structure that primes templated extension, with between 1 and
3 residues typically added (Fig. 1B). To examine the effect of
template length on 30 extension, reactions were performed using
the same templates as those described above, but in this case GTP
(including [α32P] GTP) was the only NTP included (Fig. 4D, lanes 2,
4, 6, 8 and 10). These reaction conditions would allow addition of
the ﬁrst nucleotide by 30 extension, but would not support de novo
RNA synthesis. As anticipated no signal corresponding to 30
nucleotide addition was observed for the trc 12 or 14 nt RNAs
(Fig. 4D, lanes 2 and 4), but products one residue longer than the
input RNAwere observed for the trc 16, 20 and 25 nt RNAs (Fig. 4D,
lanes 6, 8 and 10), consistent with 30 extension occurring by back-
priming. The frequency of 30 extension increased with templates
Z20 nt (Fig. 4D, compare lanes 6 and 8; Fig. 4F), which indicated
that either the longer RNA molecules or speciﬁc nucleotides
beyond position 16 enhanced the process. In addition, whereas
the 25 nt template yielded 30 extension products that were
predominantly 26, 27 and 28 nt in length, the 20 nt template
yielded relatively high levels of a product that was 26 nt in length
and labeled with GTP and ATP, consistent with the RdRp having
performed 30 extension to the end of the template (Fig. 4C, lane 6;
Fig. 4D, lane 7). This result suggested that nucleotides between
positions 21 and 25 affect the ability of the RdRp to cease 30
extension after addition of one to three nucleotides. Thus, these
data show that the 30 16 nt of trc are sufﬁcient for 30 extension to
occur. However, 20 nt allow signiﬁcantly more efﬁcient 30 exten-
sion activity, and a sequence beyond position 20 modulates the
RdRp to limit the number of nucleotides that are added.
The le promoter has the capability to direct 30 extension in vitro
The le promoter, located at the 30 end of the genome, has a high
degree of sequence similarity to trc (Mink et al., 1991). However,
sequence analysis of RNA from RSV infected cells had found no
evidence of nucleotides added by back-priming (Noton et al.,
2012). This was a surprising ﬁnding given that the le has the
potential to form a stronger secondary hairpin structure than trc
(Fig. 5A). Therefore, we examined if the difference in 30 extension
frequency on le and trc during infection was due to a difference in
the ability of the RdRp to add nucleotides to le and trc sequences.
First, we examined if the RdRp could add nucleotides to the 30
end of the le. Based on the predicted hairpin structure, it was
anticipated that if 30-extension occurred, an A residue would be
added ﬁrst followed by a C residue. A reaction was performed
containing a le 1–25 nt RNA, all four NTPs and an [α-32P] ATP label.
A series of products were detected in reactions containing wt
RdRp, which included products Z26 nt in length, consistent with
back-priming and 30 extension (Fig. 5B, lane 4). To conﬁrm that
these longer products were due to the predicted back-priming
Table 1
Stuttering frequency in RNA transcripts from RSV infected cells.
Genome location
of U tracta
Expected RNA product with 50
and 30 ﬂanking sequenceb
Total number of
sequences
Sequences with additional A
residues
Stuttering frequencyc
le (37–43) UGCAUAAACCAAAAAAAUGGGGCAAAU 2119 23 1.08
N (1546–1552) AAAAUCCUACAAAAAAAUGCUAAAAGA 102,910 1013 0.98
P-M (3237–3243) AUAUAGUUACAAAAAAAGGAAAGGGUG 4059 68 1.67
M (3726–3732) UAGUAACAUCAAAAAAAGUCAUAAUAC 388,235 2064 0.53
G (5297–5303) CCAAGCCCACAAAAAAACCAACCCUCA 711586 27344 3.84
F (6028–6034) CAACAAUGCCAAAAAAACCAAUGUAAC 205,158 3196 1.55
L (12306–12312) UACACAAGAGAAAAAAACAAUGCCAGU 18,763 387 1.86
L (14687–14693) ACCCUAUAACAAAAAAAGGAAUUAAUA 10,006 57 0.57
trc (6–12) 50–ACGAGAAAAAAAGUGUCAAAAAd 160 2 1.25
a The location is given for the nucleotide position of the U7 tract in the RSV A2 genome sequence, except for the trc U7 tract, which is given as its position in the RSV A2
antigenome. Note that the U6 tract that lies at nucleotides 6–11 of the le promoter was also included in the analysis.
b The A tract is indicated in boldface type, with ﬂanking sequences included, the underlined sequence was used for the search.
c Stuttering frequency is the number of transcripts with additional A residues as a percentage of the total sequences.
d Sequence term searched for was “ACACUUUUUUUCUCG”.
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structure shown in Fig. 5A, reactions were performed containing
either [α-32P] ATP alone or together with different combinations of
NTPs (Fig. 5B, lanes 5–10). This analysis indicated that ATP alone
could facilitate extension by one nucleotide (Fig. 5B, lane 5), and
inclusion of ATP and CTP could reconstitute the same pattern of
products as all four NTPs (Fig. 5B, lanes 4 and 6). This result was
consistent with addition of ACAA to le 25, as would be predicted.
There was also evidence that sequence consisting of As and Us
could be added (Fig. 5B, lane 8). This could be due to misincor-
poration of U in place of C during 30 extension. Having found that
the le could direct back-priming, the relative efﬁciencies of 30
extension of the le and trc RNAs were examined. To accomplish
this, reactions were performed containing all four NTPs, including
[α-32P] CTP. CTP is the second nucleotide added to the 30 end of le
and the third nucleotide added to the 30 end of trc. It can also be
the ﬁrst nucleotide added to the 30 end of trc if RNA folds into a
structure with nucleotides 1 and 2 base-pairing with nucleotides
15 and 16. Because C is added in a different sequential order in le
versus trc, this analysis does not allow the total levels of 30
extension to be directly compared, but it represents the most
sensitive method for measuring 30 extension and allows an
approximate indication of relative efﬁciencies. The results showed
that despite its inherently weaker RNA hairpin structure, the trc
RNA was equally or more efﬁcient at 30-template extension than le
(Fig. 5C, compare lanes 4 and 6). This result shows that the RNA
sequence affects the efﬁciency of 30-extension, and that the
frequency is not directly correlated to the inherent stability of
the stem loop structure. However, the fact that 30 extension could
occur on the le sequence in this assay, but apparently does not
occur in infected cells, suggests that during infection, the ability of
the RdRp to perform 30 extension is controlled by the presence of a
factor or factors missing from the in vitro assay.
Discussion
The ability of the RSV RdRp to have two distinct RNA synthesis
activities at the trc promoter indicates that it can adopt different
conformations when it encounters a promoter sequence. The
experiments described here begin to provide some light on which
factors do, and do not determine which activity the RdRp will
engage in.
As described above, RdRps require metal cations to catalyze
RNA synthesis and typically Mg2þ ions fulﬁll this role. There is
evidence that many RdRps also have a non-catalytic Mn2þ binding
site (Butcher et al., 2001; Ferrer-Orta et al., 2004; Hansen et al.,
1997; Malet et al., 2007; Ng et al., 2004; Poranen et al., 2008;
Tao et al., 2002; Wright et al., 2012; Yap et al., 2007). In the
presence of either Mg2þ or Mn2þ , the catalytic and non-catalytic
sites can potentially be occupied by whichever metal ion is
available. Given that Mg2þ and Mn2þ have different chemical
properties, and can have different effects on RdRp structure, it is
not surprising that a range of complex effects have been described
when Mg2þ is substituted with Mn2þ in RNA synthesis reactions
(Arnold et al., 1999, 2004; Butcher et al., 2001; Palmenberg and
Kaesberg, 1974; Ranjith-Kumar et al., 2002a, 2002b; Shim et al.,
2002). While these phenomena might represent abnormal RdRp
activities that would not occur in the Mg2þ rich cellular environ-
ment, it had been speculated that a subset of viral RdRp bound to
Mn2þ could have functional signiﬁcance, by enabling repair of
viral genomes, or increasing viral diversity (Ranjith-Kumar et al.,
2002a, 2002b; Selisko et al., 2012). In this study we asked a simple
question, speciﬁcally whether divalent cation identity could inﬂu-
ence the relative levels of 30 extension versus de novo initiation
(Fig. 3). At low concentrations of Mn2þ , de novo initiation was
stimulated relative to 30 extension (Fig. 3D). This indicated that the
Fig. 5. The 30 25 nt of le support 30-template extension in vitro. (A) Potential back-priming structures of RNAs representing the 30 25 nt of the trc and le regions, as indicated.
In the case of trc, residues 1 and 2 can base-pair with residues 13 and 14 (indicated with black dots) or residues 15 and 16, whereas le residues 1–4 can base-pair with
residues 13–16 (indicated with black dots). (B) RNA consisting of nt 1–25 of le sequence was incubated for 30 min with standard buffer and either all four NTPs or various
combinations of NTPs, as indicated, in the presence of [α-32P] ATP. Control reactions containing no RdRp or mutant RdRp containing the N812A substitution in the L protein
are shown (lanes 2 and 3). Lane 1 is a 25 nt size marker. (C) Comparison of 30-terminal extension activities of le and trc RNAs. Indicated RNA was incubated for 30 min with
standard buffer containing all four NTPs and [α-32P] CTP.
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ability of the RdRp to associate with the trc sequence in a
particular orientation and form a complex capable of RNA synth-
esis was altered by the identity of the cation. However, although
Mn2þ could stimulate de novo initiation, compared to Mg2þ it was
inefﬁcient at supporting elongation of de novo initiated RNA at any
of the tested concentrations (Fig. 3B). These results suggest that in
infected cells, RdRp binding to Mn2þ prior to interacting with the
promoter may cause the RdRp to adopt a conformation that favors
de novo initiation rather than 30 extension. However, the results
also suggest that if this were to happen, Mn2þ would need to be
replaced by Mg2þ to allow efﬁcient elongation of the de novo
synthesized RNA.
Previous studies had indicated that the 30 12 nucleotides would
be sufﬁcient for RNA synthesis to occur (Cowton and Fearns,
2005). The data presented in Fig. 4 conﬁrm that nucleotides
1–12 contain a fully functional promoter and show that inclusion
of additional sequence did not signiﬁcantly augment promoter
activity. The trc sequence downstream of nt 12 is highly conserved
between the different subgroups of RSV, and it is likely that trc
sequence downstream of nt 12 is important for genome synthesis.
However, the data presented here and in previous work (McGivern
et al., 2005) suggest that this region of the promoter fulﬁlls a
function that occurs after RNA synthesis initiation, most likely
elongation and/or encapsidation. In this in vitro assay, promoter
activity appeared to be inhibited by inclusion of 20 and 25 nt of
trc sequence. This was not simply due to formation of secondary
structure in the promoter sequence, as nucleotides 1–14 would
be sufﬁcient for this to occur. Possibly the more efﬁcient 30
extension that occurred with the longer templates diverted the
RdRp away from de novo synthesis. This may not happen in the
context of an infected cell, where other factors likely come into
play to regulate RdRp activity between de novo RNA synthesis and
30 extension.
Different lengths of trc template differed slightly in the quality
of the products that they generated. The 12, 14, and 16 nt
templates had a signiﬁcant level of premature termination one
nucleotide prior to the template end, and the 25 nt template
generated a relatively high proportion of product that terminated
two nucleotides prior. This indicated that the template sequence
and/or length could impact the ability of the RdRp to insert
nucleotides opposite to the 50 terminus, which might be similar
to ﬁndings with positive strand RNA virus RdRps (Tayon et al.,
2001). In addition, the 12, 14 and 16 nt templates gave rise to
products consistent with RdRp stuttering at the U7 tract present at
nucleotides 6–12. The levels of products generated by stuttering
diminished with increasing lengths of template, likely because this
provided an RNA sequence for the RdRp to continue moving along.
RNA seq analysis of RNA from RSV infected cells indicated that the
frequency of insertion at this site was 1.25%, a similar frequency as
at other U7 tracts in the RSV genome, and lower than at U7 tracts in
cellular RNA. This indicates that the RSV RdRp does not stutter at a
frequency above the background stuttering of the reverse tran-
scriptase used to generate cDNA for RNA-seq analysis. In addition,
in previous work in which replicative RNA from minigenome
transfected or RNA infected cells was analyzed by primer exten-
sion analysis, we did not detect stuttering at the trc promoter at a
level comparable to that observed in this in vitro assay (Noton
et al., 2012; Tremaglio et al., 2013). This can suggest that the RSV
RdRp is more error prone in the in vitro assay than it is in cells.
Alternatively, stuttering might cause the RdRp–RNA complex to
dissociate, resulting in abortive transcripts that would not have
been detected in the RNA seq or primer extension analyses.
Interestingly, the products generated by RdRp stuttering tended
to reach a maximum length of 21 to 25 nt (Fig. 4A and B), the
same length at which the RdRp releases templated RNA initiated
from both the þ1 and þ3 sites in vitro (Fig. 2, panels B and C) and
RNA initiated from the þ3 site in infected cells (Tremaglio et al.,
2013). This ﬁnding suggests that following initiation at the
promoter, the RSV RdRp has a propensity to release the RNA
transcript after approximately 21–25 nt, regardless of the
sequence of the product. It seems likely that in the context of an
infection, encapsidation by N protein before the RdRp has synthe-
sized 21–25 nt stabilizes the RdRp, allowing it to elongate further.
The results shown in Figs. 4D and 5 indicate that the RNA
sequence affects the efﬁciency and accuracy of 30 extension.
Although base-pairing can potentially occur between nucleotides
1 and 2, and 13 and 14, the data presented in Fig. 4D show that the
RdRp requires more than 16 nt of trc RNA for back-priming and 30
extension to be efﬁcient. It is possible that the extra RNA is
required for the RdRp to bind and form a stable complex. Sequence
downstream of the base-pairing site also appeared to play some
role in governing how many nucleotide additions were made, as
the 20 nt trc RNA tended to yield 30 extension products that were
extended to the end of the RNA with slightly greater frequency
than the 25 nt trc RNA. It should be noted that the 25 nt trc RNA
does not completely recapitulate the events that occur in infected
cells, as this RNA enabled base-pairing of nts 1 and 2 with nts 15
and 16, in addition to nts 13 and 14 (e.g. Fig. 5C), whereas analysis
of trc containing RNA from infected cells indicated that 30 exten-
sion involved base pairing with nts 13 and 14 only. It is possible
that additional RNA sequence and/or other factors contribute to
the accuracy of 30 extension in infected cells. The efﬁciency of 30
extension was not increased by using le sequence, which had
greater potential to adopt a stable secondary structure. This
suggests that the RdRp is largely responsible for folding the RNA
into the secondary structure required for back-priming to occur,
which is consistent with the fact that the structure within trc
would be expected to be weak or non-existent in RNA alone. In
addition, the pattern of 30 extension was similar with le and trc
sequences, with addition of two nucleotides generally being
dominant. This was the case, even though trc and le had a number
of nucleotide differences in the region where the 30 end of the RNA
folded into a secondary structure and the nucleotides added were
different. Together, these ﬁndings suggest that 30 extension is
affected by the RNA sequence, but that the RdRp itself plays a key
role in forming the secondary structure required and determining
how many nucleotides will be added.
There is clearly a difference between the efﬁciency of 30
extension in vitro versus infected cells, with it being the dominant
event at the trc promoter in vitro and occurring at the le promoter
in this in vitro assay, but not in infected cells (Noton et al., 2012).
The most likely explanation for why RNA would or would not be
modiﬁed by 30 extension is that formation of the secondary
structure required for back-priming is dependent on the RNA not
being encapsidated. In this in vitro assay, none of the RNA was
encapsidated, which could have increased the efﬁciency of 30
extension to a frequency that was much greater than in infected
cells. If encapsidation is key, there are at least two possible
explanations why the le is not modiﬁed by 30 extension. First, it
is possible that the trc RNA that is modiﬁed in RSV infected cells is
not within the antigenome, but rather is part of an L-trc read-
through mRNA. If an L-trc readthrough mRNA were generated, it
would not be expected to be encapsidated and this could allow the
end of the trc sequence to fold into the back-priming structure.
Because RSV is not ambi-sense, no corresponding RNA would exist
for le containing RNA. However, the RSV L gene end sequence
signals efﬁcient termination, with no evidence for readthrough in
a minigenome assay (Cartee et al., 2003), and so there is no strong
evidence that L-trc mRNA exists in infected cells. A second
explanation is that the trc RNA might sometimes be unencapsi-
dated, whereas the le might always, or almost always be encapsi-
dated. We have previously suggested that back-priming activity at
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the trc promoter might be a mechanism for negatively regulating
promoter activity under conditions of low N protein. This might
function to prevent genome synthesis from occurring until there is
a sufﬁciently high N protein concentration. Ensuring that genome
synthesis only occurs under conditions of high N protein concen-
tration might be necessary to avoid generation of unencapsidated
RNA complementary to mRNA, which could strongly activate
dsRNA sensors and inhibit mRNA translation. In contrast, it might
not be so important for antigenome RNA to be concurrently
encapsidated, and so a similar regulatory control might not need
to exist at the le promoter.
In summary, the data presented here show that the de novo
RNA synthesis and 30 extension activities of the RSV RdRp are
differentially affected by environmental conditions. They also
reveal new information about what RNA sequences are required
for these events to occur, and provide some insight into how 30
extension might be controlled. This information increases our
understanding of the properties of the RdRp–trc RNA complexes
and may be helpful for future functional and structural analyses of
the RSV RdRp.
Materials and methods
RSV RdRp puriﬁcation and RNA synthesis assays
The RSV L and P proteins were expressed in insect cells using
recombinant baculovirus and the L/P complex was puriﬁed as
described previously (Noton et al., 2012). RNA synthesis was
reconstituted in vitro using a similar approach as described
previously (Noton et al., 2012; Tremaglio et al., 2013), but with
some modiﬁcations. Templates consisted of PAGE puriﬁed RNA
oligonucleotides corresponding to various lengths of the trc or nt
1–25 of the le promoter, as indicated in the text. RNA (2 mM) was
combined with the puriﬁed L/P complex (containing 200 ng of L
protein) in RNA synthesis buffer. The standard reaction buffer was
50 mM Tris HCl pH 7.4, 8 mM MgCl2, 5 mM DTT, 10% glycerol,
1 mM each NTP, and 10 mCi of either [α32P], or [γ-32P] ATP or GTP in
a ﬁnal volume of 50 ml. Reactions were incubated at 30 1C for the
indicated lengths of time, followed by incubation at 90 1C for
3 min to inactivate the RdRp, and cooled on ice. With the
exception of the experiment shown in Fig. 2A, reactions involving
[α32P] NTPs were combined with 20 U calf intestinal alkaline
phosphatase (NEB), and incubated at 37 1C for 1 h. Reactions
involving [γ-32P] NTPs were incubated with 1 U of terminator
exonuclease (Epicentre) and further incubated for 1 h at 30 1C,
heated to 90 1C for 3 min and cooled brieﬂy on ice, to remove
template RNA that had become labeled by kinase activity that is
present in the L/P preparation. These reactions were then com-
bined with 7.5 μl 10% SDS, 0.5 μl 500 mM EDTA and 10 μg protei-
nase K and incubated at 45 1C for 45 min. RNA was isolated
by phenol–chloroform extraction and ethanol precipitation and
then resuspended in water and diluted in an equal volume of stop
buffer (deionized formamide containing 20 mM EDTA, bromophe-
nol blue, xylene cyanol). One-third of the reaction products were
analyzed by electrophoresis on a 20% polyacrylamide gel contain-
ing 7 M urea in Tris–borate–EDTA buffer, followed by auto-
radiography. The nucleotide lengths of the RNA products were
determined by comparison with a molecular weight ladder gen-
erated by alkaline hydrolysis of a [γ-32P] end-labeled RNA oligo-
nucleotides representing the anticipated 23 and/or 25 nucleotide
tr RNA products. The data were quantiﬁed by analyzing TIF images
of the autoradiograms using Quantity One software. To ensure that
the values obtained were in the linear range, a standard curve was
generated by preparing a two-fold dilution series of one of the
markers. This standard was included on all scans.
Sequence analysis of RSV RNA
RNA was isolated from A549 or HEp-2 cells infected with RSV
strain A2 using an RNeasy kit (Qiagen). Poly A enriched RNA was
fragmented and reverse transcribed. The cDNA fragments were
sequenced using an Illumina HiSeq platform to generate 50
million 100 bp paired end reads for each sample. Sequence reads
were aligned to either a canonical list of human transcripts
(215,621 transcripts) or the RSV-A2 genome using Bowtie 2 with
default parameters (Langmead and Salzberg, 2012). The output ﬁle
of sequence reads mapping to the RSV genome was converted
from BAM to SAM format and the resulting SAM ﬁles were
searched for sequences that exactly matched the target run of
sequences or for those that matched, but with any number of
additional A nucleotides inserted, as indicated in the Results
section. As a control we used this approach to examine the results
of mapping to the human genome looking at poly A rich sequences
that matched a similar sequence to that of the RSV G glycoprotein.
The data shown in Table 1 were derived from RNA isolated from
A549 cells; similar results were obtained for RNA isolated from HEp-
2 cells.
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